Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

CVRx, Inc.

CVRXNASDAQ
Healthcare
Medical - Devices
$6.76
$1.48(27.95%)
U.S. Market is Open • 12:31

CVRx, Inc. Fundamental Analysis

CVRx, Inc. (CVRX) shows moderate financial fundamentals with a PE ratio of -3.07, profit margin of -94.10%, and ROE of -99.33%. The company generates $0.1B in annual revenue with strong year-over-year growth of 30.53%.

Key Strengths

Cash Position47.26%
Current Ratio7.63

Areas of Concern

ROE-99.33%
Operating Margin-90.49%
PEG Ratio2.07
We analyze CVRX's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -135.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-135.1/100

We analyze CVRX's fundamental strength across five key dimensions:

Efficiency Score

Weak

CVRX struggles to generate sufficient returns from assets.

ROA > 10%
-50.87%

Valuation Score

Moderate

CVRX shows balanced valuation metrics.

PE < 25
-3.07
PEG Ratio < 2
2.07

Growth Score

Moderate

CVRX shows steady but slowing expansion.

Revenue Growth > 5%
30.53%
EPS Growth > 10%
-33.17%

Financial Health Score

Moderate

CVRX shows balanced financial health with some risks.

Debt/Equity < 1
1.29
Current Ratio > 1
7.63

Profitability Score

Weak

CVRX struggles to sustain strong margins.

ROE > 15%
-9932.55%
Net Margin ≥ 15%
-94.10%
Positive Free Cash Flow
No

Key Financial Metrics

Is CVRX Expensive or Cheap?

P/E Ratio

CVRX trades at -3.07 times earnings. This suggests potential undervaluation.

-3.07

PEG Ratio

When adjusting for growth, CVRX's PEG of 2.07 indicates potential overvaluation.

2.07

Price to Book

The market values CVRx, Inc. at 4.17 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

4.17

EV/EBITDA

Enterprise value stands at -3.98 times EBITDA. This is generally considered low.

-3.98

How Well Does CVRX Make Money?

Net Profit Margin

For every $100 in sales, CVRx, Inc. keeps $-94.10 as profit after all expenses.

-94.10%

Operating Margin

Core operations generate -90.49 in profit for every $100 in revenue, before interest and taxes.

-90.49%

ROE

Management delivers $-99.33 in profit for every $100 of shareholder equity.

-99.33%

ROA

CVRx, Inc. generates $-50.87 in profit for every $100 in assets, demonstrating efficient asset deployment.

-50.87%

Following the Money - Real Cash Generation

Operating Cash Flow

CVRx, Inc. generates limited operating cash flow of $-40.31M, signaling weaker underlying cash strength.

$-40.31M

Free Cash Flow

CVRx, Inc. generates weak or negative free cash flow of $-40.90M, restricting financial flexibility.

$-40.90M

FCF Per Share

Each share generates $-1.55 in free cash annually.

$-1.55

FCF Yield

CVRX converts -25.06% of its market value into free cash.

-25.06%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-3.07

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

2.07

vs 25 benchmark

P/B Ratio

Price to book value ratio

4.17

vs 25 benchmark

P/S Ratio

Price to sales ratio

2.90

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

1.29

vs 25 benchmark

Current Ratio

Current assets to current liabilities

7.63

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.99

vs 25 benchmark

ROA

Return on assets percentage

-0.51

vs 25 benchmark

ROCE

Return on capital employed

-0.56

vs 25 benchmark

How CVRX Stacks Against Its Sector Peers

MetricCVRX ValueSector AveragePerformance
P/E Ratio-3.0729.43 Better (Cheaper)
ROE-99.33%800.00% Weak
Net Margin-94.10%-20145.00% (disorted) Weak
Debt/Equity1.290.30 Weak (High Leverage)
Current Ratio7.634.64 Strong Liquidity
ROA-50.87%-17936.00% (disorted) Weak

CVRX outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews CVRx, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-82.49%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

91.25%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

93.46%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ